In focus
Latest feed
A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus
The No Surprises Act's Unintended Consequence: A Multi-Billion Dollar Headache for Healthcare
A Glimmer of Hope: India's Leap in Cervical Cancer Treatment Research
ICMR Hands Over Indigenous Cancer and Vaccine Technologies to Indian Pharma Leaders
